MAPS Press Release: FDA Agrees to Expanded Access Program for MDMA-Assisted Psychotherapy for PTSD

from MAPS.org

Big News! MDMA-Assisted Psychotherapy Expanded Access program has been accepted by the FDA! The FDA will be allowing only a limited number of patients (less than 50 in the entire country) to enroll outside of the phase III trial. This is an incredible moment in the approval process.

Here at SoundMind, will be closing on our property at 46th and Spruce Streets in a week, and then opening to see patients for psychotherapy in approximately 3 months. We will have our space renovated and ready so we can offer MDMA-Assisted Psychotherapy as soon as it is available for medical use.

We are so excited to be positioning our clinic to be among the first sites in the country to offer this treatment, and we will keep you all posted as we get our site ready to be up and running! We are ecstatic about this opportunity.

In three months, when we aren't yet offering MDMA-Assisted Psychotherapy, our clinicians will be available to offer a variety of different therapies, for PTSD and other conditions. Please join our mailing list to be kept abreast of our progress. Thank you for your support and enthusiasm!